✦ LIBER ✦

Non-Hodgkin's lymphomas—current status of therapy and future perspectives

✍ Scribed by W. Hiddemann

Book ID: 116166478
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 666 KB
Volume: 31
Category: Article
ISSN: 0959-8049
DOI: 10.1016/0959-8049(95)00367-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hodgkin's disease: Historical perspectiv

Hodgkin's disease: Historical perspective, current status, and future directions

✍ Mortimer J. Lacher 📂 Article 📅 1985 🏛 American Cancer Society 🌐 English ⚖ 866 KB

Therapy of non-Hodgkin's lymphoma

✍ J. Coffey; D. C. Hodgson; M. K. Gospodarowicz 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 160 KB

Current status and future perspectives f

Current status and future perspectives for yttrium-90 (90Y)-ibritumomab tiuxetan in stem cell transplantation for non-Hodgkin's lymphoma

✍ Gisselbrecht, C; Bethge, W; Duarte, R F; Gianni, A M; Glass, B; Haioun, C; Marti 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 223 KB

Surgical therapy of gastrointestinal non

Surgical therapy of gastrointestinal non-Hodgkin's lymphomas

✍ M. Ernst; H. Stein; D. Ludwig; J. Boese-Landgraf; J. Ritz; R. Häring 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 364 KB

Bendamustine in the treatment of non-Hod

Bendamustine in the treatment of non-Hodgkin's lymphoma: Results and future perspectives

✍ Mathias J. Rummel; Paris S. Mitrou; Dieter Hoelzer 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 110 KB

Interferon therapy of non-Hodgkin's lymp

Interferon therapy of non-Hodgkin's lymphoma

✍ Kenneth A. Foon; Mark S. Roth; Paul A. Bunn Jr 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 2 views

In 1981, the National Cancer Institute undertook Phase I1 trials of interferon alfa-2a in patients with non-Hodgkin's lymphoma (including cutaneous T-cell lymphoma [CTCL]) and chronic lymphocytic leukemia (CLL). A dose of 50 X lo6 U/m2, three times per week, was used initially, then adjusted downwar